INDOCO REMEDIES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 321.7 INR | +0.44% |
|
+1.50% | -18.60% |
| May. 16 | Indoco Remedies Gets Zero Observations from US FDA for Navi Mumbai, India Plant, IAS Division | MT |
| May. 16 | Transcript : Indoco Remedies Limited, Q4 2024 Earnings Call, May 16, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 354M | - | - | ||||
| 693B | ||||||
| 584B | ||||||
| 372B | ||||||
| 332B | ||||||
| 294B |
